Marat Adessovich Magomedov

Marat Adessovich Magomedov

Auto-generated profile, based on publicly available information

Marat Adessovich Magomedov

Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia; N.I. Pirogov City Clinical Hospital No 1, Moscow, Russia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2022 in Annals of Critical Care
Verified
Journal Article
Open access
IZIgor B. Zabolotskikh
Igor B. Zabolotskikh
NTN. V. Trembach
N. V. Trembach
TMT. S. Musaeva
T. S. Musaeva
PDP. V. Dunts
P. V. Dunts
VGV. V. Golubtsov
V. V. Golubtsov
VKV. E. Khoronenko
V. E. Khoronenko
INTRODUCTION: Advances in modern anesthesiology have significantly reduced the risk of anesthesia compared to the last century, however, the level of perioperative in-hospital mortality after elective major abdominal surgery is still high at the moment. Poor outcome prediction is the cornerstone of individualized perioperative management of high-risk patients aimed at preventing complications. Despite the fact that a large number of risk assessment tools have been developed over the past decades, the accuracy of the forecast is still far from required. According to the literature data, models based on the study of risk factors in the national population of patients, of which comorbidities make the greatest contribution, have the greatest accuracy. MATERIALS AND METHODS: Design: prospective observational study. Setting: National multicenter study of patients in surgical hospitals. Patients: Patients undergoing abdominal surgery. Interventions: Not provided. RESULTS: The developed design was registered in the ClinicalTrials.gov database, a study organized by the Federation of Anesthesiologists and Resuscitators of Russia in cooperation with the Kuban State Medical University has now begun, 38 centers are participating in it, two papers have been published based on the results of an interim analysis. CONCLUSIONS: The study is of great scientific and medical and social importance, as a result of the analysis of the data obtained, the role of concomitant diseases in the development of an adverse outcome will be studied and a national risk assessment model will be developed.

16 November 2020 in Annals of Critical Care
Verified
Journal Article
Open access
IZIgor B. Zabolotskikh
Igor B. Zabolotskikh
NTN. V. Trembach
N. V. Trembach
MMM. A. Magomedov
M. A. Magomedov
VKV. G. Krasnov
V. G. Krasnov
LCL. Yu. Chernienko
L. Yu. Chernienko
DPD. N. Protsenko
D. N. Protsenko
Introduction. Despite the advances in modern anesthesiology, it is impossible to guarantee a safe course of anesthesia, and even with planned surgical interventions, there is a risk of death. At present, there is no unanimity in approaches to assessing perioperative risk, and many systems for determining this risk have not been validated in Russia. The question of the contribution of pre-operative factors to the likelihood of an unfavorable outcome also remains open, which requires large multicenter national studies. Objectives. To assessment the predictive value of preoperative factors in determining the risk of death and complications based on the analysis of data obtained during the first year of the STOPRISK study. Materials and methods. An analysis of data on perioperative indices of 3002 patients operated on the abdominal and pelvic organs from 30 centers in 21 cities of Russia participating in the STOPRISK study is presented. Results. The mortality rate in the study was 0.47 %, the rate of postoperative complications was 3.9 %. Most often, an unfavorable outcome developed after upper abdominal and colorectal surgery. Despite the fact that the severity of surgery and the ASA class are independent predictors of an unfavorable outcome, the use of these parameters allows to predict postoperative mortality (AUROC = 0.85) and (with age) postoperative complications (AUROC = 0.77) with limited accuracy. Conclusions. Thus, the probability of an unfavorable outcome can be estimated using factors such as the severity of surgery and the initial physical status, but their predictive value for determining the risk of mortality is clearly insufficient, and even less is their ability to assess the risk of postoperative complications. As shown by literature data, inclusion in model additional risk factors allows to increase the accuracy of the forecast, however, given the peculiarities of the structure of comorbidities and their impact on outcome in the studied population, we need further evaluation of their contribution to perioperative risk. Also, taking into account the peculiarities of the occurrence of some concomitant diseases, further research is required to identify a significant impact on mortality and postoperative complications.

28 July 2023 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
IZIgor B. Zabolotskikh
Igor B. Zabolotskikh
NTN. V. Trembach
N. V. Trembach
MMM. A. Magomedov
M. A. Magomedov
APA. S. Popov
A. S. Popov
YMYu. P. Malyshev
Yu. P. Malyshev
DFD. E. Fedunets
D. E. Fedunets
INTRODUCTION: Risk assessment and identification of a group of patients with a high probability of developing an unfavorable outcome is the basis for effective prevention of postoperative adverse events. OBJECTIVE: The purpose of the study was to determine the structure and frequency of co-existing diseases in the preoperative period and associated adverse postoperative outcomes. MATERIALS AND METHODS: The analysis of the parameters of 8,241 patients of the STOPRISK database operated on abdominal and pelvic organs for the period from July 1, 2019 to April 30, 2022 was carried out. RESULTS: Co-existing diseases occurred in 4,638 patients (56.3 %), while one disease was observed in 1,872 patients (22.7 %), a combination of two diseases — in 1,383 patients (16.8 %), three diseases — in 814 patients (9.9 %), four diseases — in 395 patients (4.8 %), and more than 4 — in 170 patients (2.0 %). The most common were arterial hypertension — 48.2 %, chronic heart failure (20.7 %), coronary heart disease (19.3 %). The presence of one or more complications was recorded in 285 patients (3.5 %), fatal outcome — in 36 patients (0.43 %). 74.0 % of patients had a single complication, 14.0 % had a combination of two complications, and 12.0 % had a combination of three or more complications. The structure of complications was dominated by paralytic ileus (25.57 %), pneumonia (12.1 %), wound infection (12.1 %). Both mortality and the frequency of complications increased with an increase in the number of co-existing diseases. CONCLUSIONS: The most common co-existing diseases in abdominal surgery are arterial hypertension, chronic heart failure, coronary heart disease, diabetes mellitus and cardiac arrhythmia. The frequency of postoperative complications was 3.5 %, mortality was 0.43 %; the most frequent complications were paralytic ileus, wound infection and pneumonia.

30 October 2023 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
SRS. I. Rey
S. I. Rey
VKV. V. Kulabukhov
V. V. Kulabukhov
APAleksander Popov
Aleksander Popov
ONO. V. Nikitina
O. V. Nikitina
GBG. A. Berdnikov
G. A. Berdnikov
VPVladimir Pisarev
Vladimir Pisarev
INTRODUCTION: Septic shock is the most serious complication in intensive care that associates with significant mortality. Extracorporeal hemocorrection may improve treatment of patients with septic shock. OBJECTIVE: Evaluation of the effect of hemocorrection with the multimodal adsorbent device Efferon LPS on the dynamics of organ dysfunction and inflammation markers in patients with septic shock. MATERIALS AND METHODS: A multicenter randomized controlled study was conducted in four clinical organizations in the city of Moscow from March 2021 to May 2022. The study included 58 patients (29 men and 29 women) with septic shock. Randomization was performed in a ratio of 2:1 (hemoperfusion: control). Within 24 hours of enrollment in the study, selective hemoperfusion procedures were performed or standard therapy was used. Hemosorption using Efferon LPS was performed twice, with an interval of 24.5 (23.3–26.0) hours. RESULTS: The use of the multimodal selective hemosorbent Efferon LPS significantly reduced the severity of multiple organ failure (MOF) in patients with septic shock from 7 to 3 points on the SOFA scale after 72 hours by improving hemodynamics, respiratory and renal function. In contrast to the control group, in the Efferon LPS group, the levels of CRP, PCT and IL-6 significantly decreased in 72 hours. The severity of MOF significantly correlated with the level of CRP and PCT (Spearman’s r = 0.346 and r = 0.444, respectively). The duration of hospitalization in survived patients was 16.1 days and 30.1 days in the Efferon LPS and control group, respectively (p = 0.032). The need for a renal replacement therapy (RRT) in survivors by the 3rd day was significantly reduced only in the Efferon LPS group — from 73.7 to 33.3 %. CONCLUSIONS: The use of the selective hemosorbent Efferon LPS resulted in significant decreases the hallmarks of systemic inflammation, MOF and requirements for RRT in patients with septic shock.

1 January 2022 in Russian Journal of Anesthesiology and Reanimatology
Verified
Journal Article
Closed access
TKT.G. Kim
T.G. Kim
DPD.N. Protsenko
D.N. Protsenko
MMM.A. Magomedov
M.A. Magomedov
MZM.V. Zakharov
M.V. Zakharov
AMA.V. Marukhov
A.V. Marukhov
NCN.V. Chubchenko
N.V. Chubchenko
Септический шок является наиболее опасным проявлением сепсиса. В 55—73% случаев течение септического шока осложняется развитием острого повреждения почек, что ведет к увеличению показателя летальности до уровня, превышающего 60%. ЦЕЛЬ ИССЛЕДОВАНИЯ Сопоставить детоксикационную эффективность применения различных современных методов эфферентной терапии при лечении пациентов с септическим шоком, осложненным острым повреждением почек, путем изучения динамики уровня эндотоксина и цитокинов крови. МАТЕРИАЛ И МЕТОДЫ В проспективное исследование включены 85 пациентов с септическим шоком, осложненным острым повреждением почек, при лечении которых применяли различные методы экстракорпоральной детоксикации. Пациенты разделены на три группы в соответствии с тактикой экстракорпоральной детоксикации. При проведении исследования изучали динамику уровня активности эндотоксина, концентрации интерлейкинов (ИЛ) ИЛ-1β, ИЛ-6 и фактора некроза опухоли альфа (ФНО-α) в крови пациентов, а также исходы заболевания. РЕЗУЛЬТАТЫ Наиболее выраженное снижение уровня активности эндотоксина, концентрации ИЛ-1β, ИЛ-6 и ФНО-α в крови наблюдалось при применении комбинации продленной гемодиафильтрации и селективного плазмообмена: на 39,3, 53,%, 74,2 и 71,7% соответственно. При изолированном использовании гемодиафильтрации статистически значимого снижения уровня данных факторов эндогенной интоксикации за время проведения экстракорпоральной детоксикации не наблюдалось. Наилучший показатель выживаемости также характерен для группы применения гемодиафильтрации и селективного плазмообмена — 71,4%. ЗАКЛЮЧЕНИЕ Комбинированное применение методов экстракорпоральной детоксикации может улучшить результаты лечения пациентов с септическим шоком и острым повреждением почек за счет более высокой детоксикационной эффективности.

28 July 2023 in Annals of Critical Care
Verified
Journal Article
Open access
PDF file
SMS. V. Masolitin
S. V. Masolitin
DPDenis N. Protsenko
Denis N. Protsenko
ITI. N. Tyurin
I. N. Tyurin
TKT. G. Kim
T. G. Kim
MMM. A. Magomedov
M. A. Magomedov
AYA. V. Yaralyan
A. V. Yaralyan
INTRODUCTION: Morbidity and mortality of severe acute pancreatitis (SAP) remains high. The most important direction of therapy is the relief of endotoxicosis. The use of extracorporeal detoxification (ECD) is a debatable problem. OBJECTIVE: Improving the results of treatment of patients with SAP, through the use of ECD methods. MATERIALS AND METHODS: The study included 25 patients. Group 1: ECD included 9 patients who used standard therapy with selective hemoperfusion (HP) and continuous veno-venous hemofiltration (CVVHF). Group 2 (control) 16 patients received standard therapy. We performed a comparative analysis of the main clinical and laboratory parameters and treatment outcomes between the groups. RESULTS: The use of ECD allowed to reduce the number of leukocytes from 14.9 to 8.6 × 109/l by 5 days of therapy in group 1, and from 17.6 to 16.1 × 109/l in group 2, respectively. The dynamics of CRP concentration from 1 to 5 days changed from 315.6 to 184.6 mg/ml and 274.2 to 352.9 mg/ml in groups 1 and 2, respectively. The level of PCT concentration on days 1–5 decreased from 4.5 to 2.1 ng/ml and 3.95 to 6.9 ng/ml in groups 1 and 2, respectively. The concentration of IL-6 decreased from 1624.3 to 914.3 pg/ml in group 1, and increased from 1529.8 to 1861.8 pg/ml in group 2, respectively. The dynamics of pH in group 1 was from 7.14 to 7.4 by the 5th day of therapy and 7.13 to 7.22 in group 2, respectively. SOFA by day 5 in group 1 was 4 points and 11 points in group 2, respectively. CONCLUSIONS: The use of HP and CVVHF in complex intensive care is accompanied by a significant regression of markers of endogenous intoxication, resolution of the acid-base state and reduces the severity of organ dysfunction and the risk of adverse outcomes, compared with standard treatment.